An interventional study of Galactagogue Supplement for Treatment of Low Milk Supply in Breast Milk Expression, sponsored by Winthrop University. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-28.
Sponsored by Winthrop University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Breast Milk Expression with a site in United States — 6 open to participants now, 10 under way, none of them phase 3. Breast Milk Expression · United States.
Among the 32 studies in Breast Milk Expression with a site in United States, this one is the 7th largest by planned enrollment of the 22 interventional ones that give a count, is one of 2 that started in 2024, is one of 21 with no phase, and was the 22nd registered.
88 studies on the registry are indexed under Breast Milk Expression; 19 are open to participants now.
Browse Breast Milk Expression studies →6 of the 32 studies in Breast Milk Expression with a site in United States are open now. Recruiting first, the newest first:
Arkansas Children's Hospital Research Institute · Sites in United States
Ages 18+ · Women only
Mayo Clinic · Sites in United States
Ages 20+ · Women only · Healthy volunteers
Thomas Jefferson University · Sites in United States
Ages 18+ · Women only
University of Alabama at Birmingham · Sites in United States
Ages up to 28 days
University of Idaho · Sites in United States
Ages 18+ · Women only · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 13 Breast Milk Expression studies recruiting now, 6 (46%) set no upper age limit and 7 (54%) stop at 75 or younger; 3 take children under 18; 10 take healthy volunteers.
This study: 18 Years to 40 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 60 across 49 interventional studies indexed under Breast Milk Expression.
Median enrollment 52 across the 22 interventional studies, 30 across the 10 observational. Of the 16 that completed or were terminated, 2 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 32 have an industry lead sponsor. The 10 most frequent:
Winthrop University is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Winthrop University has 1 study filed under Breast Milk Expression — fewer than ten, so there is no comparison to draw.
2 of the studies in Breast Milk Expression with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03977259Brigham and Women's HospitalTargeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development | 2027-08-31 |
| NCT06673160University of Alabama at BirminghamPumping to Up Maternal Milk Production for Preterms | 2027-09 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Breast Milk Expression with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to determine whether a 20-day supplement with either Oat Mama Lactation Supplement, moringa, or shatavari has any impact on milk production through an increase in serum prolactin levels when compared to the placebo group. This data will be used to determine if clinical recommendations can be made for the use of the studied supplements in increasing milk supply.
This study will be a double-blind randomized control trial where eligible participants will be randomized into one of four treatment groups: Oat Mama Lactation Supplement (O), moringa supplement (M), shatavari supplement (S), or control (C). All participants will receive a supplement or placebo for consumption throughout the 20-day trial period, and all participants will receive support from a lactation consultant once per week to receive appropriate guidance for increasing milk supply. 24-hour milk output will be recorded on day 1, 10, and 20 using either pre- and post-feeding weights, 24-hour pump output, or a combination of both. Additionally, blood samples will be taken on day 1, 10, and 20 and serum will be isolated for later analysis of serum prolactin levels.
Inclusion Criteria: Participants in the study must:
Exclusion Criteria: Participants will be excluded if:
Participants will receive a 20 day supply of oat mama lactation supplement for consumption per the manufacturer instructions
Dietary Supplement: Galactagogue Supplement for Treatment of Low Milk Supply
Participants will receive a 20 day supply of moringa supplement for consumption per the manufacturer instructions
Dietary Supplement: Galactagogue Supplement for Treatment of Low Milk Supply
Participants will receive a 20 day supply of shatavari supplement for consumption per the manufacturer instructions
Dietary Supplement: Galactagogue Supplement for Treatment of Low Milk Supply
Participants will receive a 20 day supply of placebo pills containing a mixture of flour and brown sugar. Participants will consume 2 placebo pills once per day for 20 days.
Dietary Supplement: Galactagogue Supplement for Treatment of Low Milk Supply
Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply
Change in Breast Milk Supply
Change in breast milk supply will be evaluated using 24-hour breast milk expression volume
Time frame: Intervention will last 20 days and 24-hour breast milk expression volume will be measured on day 1, 10, and 20 and used to calculate change in 24-hour breast milk expression volume over the trial period
Change in Serum Prolactin
Change in serum prolactin levels will be evaluated by taking blood samples on day 1, 10, and 20 and measuring serum prolactin using a human serum prolactin ELISA kit
Time frame: Intervention will last 20 days and blood samples will be taken on day 1, 10, am 20 and change in serum prolactin will be measured using a human serum prolactin ELISA kit
Plan to share: No — There will be no sharing of individual participant data to researchers outside of the experimental team.
No publications or documents are linked to this record.
Started Mar 2024 (actual). Primary completion is estimated for Jun 2025, 14 months after the start.
Of 32 non-industry interventional studies with no phase under Breast Milk Expression, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 28. This study's planned 14 months is close to that.
Counting every sponsor, half of 39 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Winthrop University